Generation of donor-specific immunotolerance in renal-allograft recipients

Generation of donor-specific immunotolerance in renal-allograft recipients

The kidney cannot be successfully grafted without immunosuppressive therapy. A unicenter retrospective study has evaluated the efficiency of immunosuppression with daclizumab (Zenapax) versus alemtuzumab (Campath).Subjects and methods. After renal allotransplantation, 64 patients, including 34 and 3...

Full description

Saved in:
Bibliographic Details
Main Authors: V. A. Goryainov, M. M. Kaabak, M. M. Morozova, L. A. Shishlo, N. N. Babenko, A. K. Zokoyev
Format: Article
Language:English
Published: N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department 2018-08-01
Series:Трансплантология (Москва)
Subjects:
(allogenic) renal transplantation
immunosuppression
comparative study
campath
zenapax
Online Access:https://www.jtransplantologiya.ru/jour/article/view/240
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items